Contact:
(U.S.) Andrew Goldman, KEI: andrew.goldman@keionline.org or +1 (202) 332-2670
(Colombia) Andrea Carolina Reyes Rojas, Misión Salud: subdireccion@mision-salud.org
(Colombia) Dr. Francisco Rossi, IFARMA: francisco_rossi@hotmail.com (More on Colombia here: /colombia)
Washington, DC — Today, 28 organizations that support the advancement of public health, as well as the successful continuation of the peace process in Colombia, urged President Obama to voice U.S. support for Colombia’s right to grant a compulsory license on an expensive leukemia drug. Continue Reading →
On May 24, 2016, Colombia’s Minister of Health, Alejandro Gaviria, made an intervention at the World Health Assembly that referred to the pressure Colombia has been facing with regard to the potential compulsory license for imatinib and called for the WHO to support members to ensure sustainable development through the regulation of pharmaceutical monopolies and promoting competition, transparency, and the rational use of drugs. Continue Reading →
(More on Colombia here: /colombia) For more information, contact: (U.S.) Andrew Goldman, KEI: andrew.goldman@keionline.org or +1 (202) 332-2670 (Colombia) Andrea Carolina Reyes Rojas, Misión Salud: subdireccion@mision-salud.org (Colombia) Dr. Francisco Rossi, IFARMA: francisco_rossi@hotmail.com Frequently Asked Questions What is happening in Colombia… Continue Reading →
For more information, contact:
(U.S.) Andrew Goldman, KEI: andrew.goldman@keionline.org or +1 (202) 332-2670
(Colombia) Andrea Carolina Reyes Rojas, Misión Salud: subdireccion@mision-salud.org
(Colombia) Dr. Francisco Rossi, IFARMA: francisco_rossi@hotmail.com
Frequently Asked Questions
What is happening in Colombia with regard to imatinib? Continue Reading →
(More on government funded inventions here. Other KEI comments on NIH licenses are found here.) May 16th, 2016 Sally Hu, Ph.D., M.B.A., Senior Licensing and Patenting Manager, Office of Technology Transfer and Innovation Access, National Institute of Dental and Craniofacial… Continue Reading →
Chair: Brazil, you still have the floor.
>> BRAZIL: Thank you, Chair.
Regarding a very quick follow-up to your question regarding — as I mentioned, the proposal was presented and supported in 201 and 204 of the draft report and we understand it should be also reflected. We understand that this could be also a bridge of positions getting comfort to many Delegations that have concerns on this matter. These are the details that you have requested. Thank you, Chair.
>> CHAIR: Thank you for that. Continue Reading →
II. OBJECT OF PROTECTION
(1) The protection granted under this Treaty extends only to programme-carrying signals
[including pre-broadcast signals] transmitted by, or on behalf of, a broadcasting [or a
cablecasting] organization[, but not to programmes contained therein].
(2) The provisions of this Treaty shall not provide any protection in respect of mere
retransmissions.
(3) Alternative A
Notwithstanding paragraph (2) above, broadcasting [/cablecasting] organizations shall Continue Reading →
